Where can I find news about IRIX?

The latest headlines, third-party analysis, and SEC filings for IRIDEX Corporation (IRIX) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.

Where are IRIX's SEC filings?

IRIDEX Corporation (IRIX)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

Where are IRIX's earnings call transcripts?

Full earnings call transcripts for IRIDEX Corporation (IRIX) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

IRIX

IRIDEX Corporation

NASDAQ·Medical, Devices · Healthcare

$0.71$0.00+0.69%

After hours·$0.71+0.00%

Market cap$12.33M·Market closed·Aug 27 8:00 PM UTC

News & Analysis

IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%
IRIX's Q2 loss per share widens year over year and revenues decline as Middle East disruptions and reduced sell-through in China weigh on retina sales, offsetting continued growth in the Cyclo G6 product family.
zacks.comAug 25, 2026 · 2:46 PM
IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript
IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript
seekingalpha.comAug 18, 2026 · 8:01 PM
Iridex Reports Second Quarter 2026 Financial Results
MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today reported financial results for the second quarter ended July 4, 2026.
globenewswire.comAug 18, 2026 · 4:05 PM
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
MOUNTAIN VIEW, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the second quarter 2026 and provide a business update after the close of trading on August 18, 2026.
globenewswire.comAug 4, 2026 · 4:05 PM
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
MOUNTAIN VIEW, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced the expansion of its EyeProGPO product offering to include the Company's line of EndoProbe® Handpieces.
globenewswire.comJul 20, 2026 · 7:00 AM
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Planet MicroCap Las Vegas 2026 Conference.
globenewswire.comJun 9, 2026 · 4:05 PM
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth
IRIDEX posts a narrower year-over-year net loss per share in Q1'26 as strong glaucoma product sales and lower operating costs helped offset weakness in retina sales and supply-chain disruptions.
zacks.comMay 25, 2026 · 2:01 PM
IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript
IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript
seekingalpha.comMay 19, 2026 · 6:10 PM

SEC Filings

10-Q
Aug 18, 2026View on SEC
8-K
Aug 18, 2026View on SEC
8-K
Jul 16, 2026View on SEC
SC 13D/A
Jul 13, 2026View on SEC
8-K
Jun 18, 2026View on SEC
SD
Jun 1, 2026View on SEC

Frequently Asked Questions About IRIX

Where can I find news about IRIX?: The latest headlines, third-party analysis, and SEC filings for IRIDEX Corporation (IRIX) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are IRIX's SEC filings?: IRIDEX Corporation (IRIX)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are IRIX's earnings call transcripts?: Full earnings call transcripts for IRIDEX Corporation (IRIX) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

IRIDEX Corporation

Frequently Asked Questions About IRIX

IRIDEX Corporation

IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%

IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript

Iridex Reports Second Quarter 2026 Financial Results

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript

Frequently Asked Questions About IRIX

IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%

IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript

Iridex Reports Second Quarter 2026 Financial Results

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript